DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 USDMF, 1 JDMF, 2 NDC API, 1 Listed Suppliers, $ API Reference Price

3 API Suppliers
2 USDMF
1 JDMF
2 NDC API
1 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 4 FDA Orange Book

4 FDF Dossiers
4 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

POWDER;ORAL - EQ 16.8GM BASE/PACKET, POWDER;ORAL - EQ 1GM BASE/PACKET, POWDER;ORAL - EQ 25.2GM BASE/PACKET, POWDER;ORAL - EQ 8.4GM BASE/PACKET

drugProductComposition
POWDER;ORAL - EQ 16.8GM BASE/PACKET
POWDER;ORAL - EQ 1GM BASE/PACKET
POWDER;ORAL - EQ 25.2GM BASE/PACKET
POWDER;ORAL - EQ 8.4GM BASE/PACKET

MARKET PLACE

1 APIs

marketPlace
1 APIs

PATENTS & EXCLUSIVITIES

52 US Patents, 4 US Exclusivities

patents
52 US Patents
4 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₅₀H₆₂CaF₂O₁₀

Molecular Weight

901.1 g/mol

InChI Key

KDDZXVQCHUXALQ-NIQIMLPHSA-L

1 2D Structure

Patiromer Sorbitex Calcium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

calcium;1,2-bis(ethenyl)benzene;1,3-bis(ethenyl)benzene;1,4-bis(ethenyl)benzene;2-fluoroprop-2-enoate;(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;octa-1,7-diene

2.1.2 InChI

InChI=1S/3C10H10.C8H14.C6H14O6.2C3H3FO2.Ca/c1-3-9-5-7-10(4-2)8-6-9;1-3-9-6-5-7-10(4-2)8-9;1-3-9-7-5-6-8-10(9)4-2;1-3-5-7-8-6-4-2;7-1-3(9)5(11)6(12)4(10)2-8;2*1-2(4)3(5)6;/h3*3-8H,1-2H2;3-4H,1-2,5-8H2;3-12H,1-2H2;2*1H2,(H,5,6);/q;;;;;;;+2/p-2/t;;;;3-,4+,5-,6-;;;/m....1.../s1

2.1.3 InChI Key

KDDZXVQCHUXALQ-NIQIMLPHSA-L

2.1.4 Canonical SMILES

C=CCCCCC=C.C=CC1=CC=C(C=C1)C=C.C=CC1=CC(=CC=C1)C=C.C=CC1=CC=CC=C1C=C.C=C(C(=O)[O-])F.C=C(C(=O)[O-])F.C(C(C(C(C(CO)O)O)O)O)O.[Ca+2]

2.1.5 Isomeric SMILES

C=CCCCCC=C.C=CC1=CC=C(C=C1)C=C.C=CC1=CC(=CC=C1)C=C.C=CC1=CC=CC=C1C=C.C=C(C(=O)[O-])F.C=C(C(=O)[O-])F.C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O.[Ca+2]

2.2 Create Date

2015-01-24

3 Chemical and Physical Properties

Molecular Formula	C₅₀H₆₂CaF₂O₁₀
Molecular Weight	901.1 g/mol
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	16
Exact Mass	900.3936953 g/mol
Monoisotopic Mass	900.3936953 g/mol
Topological Polar Surface Area	202 A^2
Heavy Atom Count	63
Formal Charge	0
Complexity	556
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	8

4 Drug and Medication Information

4.1 Drug Information

1 of 1
Drug Name	VELTASSA
Active Ingredient	PATIROMER SORBITEX CALCIUM
Company	RELYPSA INC (Application Number: N205739. Patents: 7556799, 8147873, 8216560, 8282913, 8287847, 8337824, 8475780, 8778324, 8889115, 9492476, 9925212)